ASX - By Stock
|
NOX |
Re:
Ann: NOX and Nyrada TechKnow Invest Roadshow Presentations
|
|
RBx
|
4 |
3.0K |
7 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
4
|
3.0K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOX and Nyrada TechKnow Invest Roadshow Presentations
|
|
RBx
|
4 |
3.0K |
17 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
4
|
3.0K
|
17
|
|
ASX - By Stock
|
NOX |
Re:
Ann: New Executive Appointments and Board Change
|
|
RBx
|
25 |
9.0K |
7 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
25
|
9.0K
|
7
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Potential Fundamental Change in Treatment of Brain Cancer
|
|
RBx
|
7 |
3.9K |
3 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
7
|
3.9K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Food for thought
|
|
RBx
|
5 |
2.6K |
6 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
5
|
2.6K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Food for thought
|
|
RBx
|
5 |
2.6K |
3 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
5
|
2.6K
|
3
|
|
ASX - By Stock
|
NOX |
Food for thought
|
|
RBx
|
5 |
2.6K |
10 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
5
|
2.6K
|
10
|
|
ASX - By Stock
|
NOX |
Re:
Ann: New Executive Appointments and Board Change
|
|
RBx
|
25 |
9.0K |
3 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
25
|
9.0K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: New Executive Appointments and Board Change
|
|
RBx
|
25 |
9.0K |
3 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
25
|
9.0K
|
3
|
|
ASX - By Stock
|
NOX |
Interesting
|
|
RBx
|
0 |
494 |
7 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
0
|
494
|
7
|
|
ASX - By Stock
|
NOX |
Patent process
|
|
RBx
|
1 |
555 |
7 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
1
|
555
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Engagement.
|
|
RBx
|
56 |
17K |
6 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
56
|
17K
|
6
|
|
ASX - By Stock
|
NOX |
GK blog on LuPSMA and LuPIN data
|
|
RBx
|
2 |
1.8K |
8 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
2
|
1.8K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Further Review Shows Major Clinical Benefits from Veyonda
|
|
RBx
|
6 |
3.6K |
8 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
6
|
3.6K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
KZA will be marching on
|
|
RBx
|
28 |
14K |
2 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
28
|
14K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
RBx
|
16 |
7.2K |
5 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
16
|
7.2K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
RBx
|
16 |
7.2K |
6 |
27/09/19 |
27/09/19 |
ASX - By Stock
|
16
|
7.2K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
share price
|
|
RBx
|
77 |
28K |
1 |
24/09/19 |
24/09/19 |
ASX - By Stock
|
77
|
28K
|
1
|
|
ASX - By Stock
|
NOX |
CLARIFICATION
|
|
RBx
|
0 |
718 |
6 |
24/09/19 |
24/09/19 |
ASX - By Stock
|
0
|
718
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Patent update
|
|
RBx
|
16 |
7.2K |
4 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
16
|
7.2K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Veyonda and Radiotherapy Profiled at Key Oncology Meeting
|
|
RBx
|
1 |
1.7K |
10 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
1
|
1.7K
|
10
|
|
ASX - By Stock
|
NOX |
Re:
EGM
|
|
RBx
|
4 |
3.3K |
14 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
4
|
3.3K
|
14
|
|
ASX - By Stock
|
NOX |
EGM
|
|
RBx
|
4 |
3.3K |
5 |
15/09/19 |
15/09/19 |
ASX - By Stock
|
4
|
3.3K
|
5
|
|
ASX - By Stock
|
NOX |
Re:
An Investment in Biotech: Part 3
|
|
RBx
|
4 |
1.7K |
3 |
11/09/19 |
11/09/19 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
NOX |
Patent update
|
|
RBx
|
16 |
7.2K |
6 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
16
|
7.2K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: CHANGE OF DIRECTOR'S INTEREST NOTICE - GK
|
|
RBx
|
12 |
4.0K |
2 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
12
|
4.0K
|
2
|
|
ASX - By Stock
|
NOX |
No need to panic
|
|
RBx
|
7 |
4.3K |
11 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
7
|
4.3K
|
11
|
|